Carlos Jose Pirola (Carlos J Pirola, C J Pirola)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 37

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Expert review of gastroenterology & hepatology

National Scientific and Technical Research Council (CONICET)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Scientific and Technical Research Council (CONICET) Mar 1o 2008

Argentina

Director :: IDIM,

Publications

Carlos Jose Pirola, Silvia Sookoian
Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent? Alimentary pharmacology & therapeutics 57 (10) (2023)
Carlos Jose Pirola, Silvia Sookoian
COVID-19 and non-alcoholic fatty liver disease: Biological insights from multi-omics data. Liver international : official journal of the International Association for the Study of the Liver (2023)
Carlos Jose Pirola, Silvia Sookoian
COVID-19 and NAFLD: biological insights from multi-omics data. Liver international : official journal of the International Association for the Study of the Liver (2023)
Carlos Jose Pirola, Silvia Sookoian
Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent? Alimentary pharmacology & therapeutics 57 (10) (2023)
Carlos Jose Pirola, Silvia Sookoian
COVID-19 and non-alcoholic fatty liver disease: Biological insights from multi-omics data. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Carlos Jose Pirola, Silvia Sookoian
Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent? Alimentary pharmacology & therapeutics 57 (10) (2023)
Carlos Jose Pirola, Silvia Sookoian
COVID-19 and non-alcoholic fatty liver disease: Biological insights from multi-omics data. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Carlos Jose Pirola, Silvia Sookoian
Non-alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension. Liver international : official journal of the International Association for the Study of the Liver (2023)
Carlos Jose Pirola, Silvia Sookoian
COVID-19 and non-alcoholic fatty liver disease: Biological insights from multi-omics data. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Carlos Jose Pirola, Silvia Sookoian
COVID-19 and non-alcoholic fatty liver disease: Biological insights from multi-omics data. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Carlos Jose Pirola, Silvia Sookoian
Advances in our understanding of the molecular heterogeneity of fatty liver disease: towards informed treatment decision making. Expert review of gastroenterology & hepatology (2023)
Carlos Jose Pirola, Silvia Sookoian
Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent? Alimentary pharmacology & therapeutics 57 (10) (2023)
Carlos Jose Pirola, Silvia Sookoian
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making. Expert review of gastroenterology & hepatology (2023)
Eduardo Valli, Tomás Dalotto-Moreno, Helena Andrea Sterle, Santiago P Méndez-Huergo, María A Paulazo, Silvia I García, Carlos Jose Pirola, Alicia J Klecha, Gabriel A Rabinovich, Graciela Alicia Cremaschi
Hypothyroidism-associated immunosuppression involves induction of galectin-1-producing regulatory T cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (4) (2023)
Adrian Salatino, Silvia Sookoian, Carlos Jose Pirola
Computational Pipeline for Next-Generation Sequencing (NGS) Studies in Genetics of NASH. Methods in molecular biology (Clifton, N.J.) 2455 (2022)
Carlos Jose Pirola, Silvia Sookoian
MicroRNAs as messengers of liver diseases: has the message finally been decrypted? Clinical science (London, England : 1979) 136 (5) (2022)
Silvia Sookoian, Carlos Jose Pirola
The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population. Journal of physiology and biochemistry (2022)
Eduardo Vilar-Gomez, Carlos Jose Pirola, Silvia Sookoian, Laura A Wilson, Tiebing Liang, Naga P Chalasani
PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features. Hepatology (Baltimore, Md.) 76 (5) (2022)
Carlos Jose Pirola, Silvia Sookoian
PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Silvia Sookoian, Carlos Jose Pirola, Luca Vittorio Valenti, Nicholas O Davidson
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. Hepatology (Baltimore, Md.) 72 (1) (2021)
Carlos Jose Pirola, Silvia Sookoian
Editorial: bariatric surgery to reduce the risk of liver cancer. Alimentary pharmacology & therapeutics 53 (10) (2021)
Carlos Jose Pirola, Silvia Sookoian
NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions. Hepatology (Baltimore, Md.) 73 (2) (2021)
Carlos Jose Pirola, Silvia Sookoian
Epigenetics factors in nonalcoholic fatty liver disease. Expert review of gastroenterology & hepatology (2020)
Silvia Sookoian, Adrian Salatino, Gustavo Osvaldo Castaño, Maria Silvia Landa, Cinthia Fijalkowky, Martin Garaycoechea, Carlos Jose Pirola
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. Gut 69 (8) (2020)
Carlos Jose Pirola, M Garaycoechea, D Flichman, G O Castaño, Silvia Sookoian
Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease. Journal of internal medicine 289 (1) (2020)
Carlos Jose Pirola, Silvia Sookoian
SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19. Liver international : official journal of the International Association for the Study of the Liver 40 (8) (2020)
Carlos Jose Pirola, Silvia Sookoian
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Alimentary pharmacology & therapeutics 48 (7) (2019)
Silvia Sookoian, Carlos Jose Pirola
Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside. Alimentary pharmacology & therapeutics 49 (5) (2019)
Carlos Jose Pirola, Martin Garaycoechea, Diego Flichman, Marco Arrese, Julio San Martino, Carla Gazzi, Gustavo O Castaño, Silvia Sookoian
Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease. Journal of lipid research 60 (1) (2018)
Silvia Sookoian, Diego Flichman, Martin E Garaycoechea, Julio San Martino, Gustavo O Castaño, Carlos Jose Pirola
Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage. Hepatology communications 2 (6) (2018)
Carlos Jose Pirola, Diego Flichman, Hernán Dopazo, Tomas Fernández Gianotti, Julio San Martino, Cristian Rohr, Martin Garaycoechea, Carla Gazzi, Gustavo O Castaño, Silvia Sookoian
A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis. Hepatology communications 2 (9) (2018)
Silvia Sookoian, Carlos Jose Pirola
The nonalcoholic steatohepatitis metabotype: Imbalance of circulating amino acids and transamination reactions reflect impaired mitochondrial function. Hepatology (Baltimore, Md.) 67 (3) (2018)
Silvia Sookoian, Carlos Jose Pirola
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Alimentary pharmacology & therapeutics 46 (2) (2017)
Mariana L Tellechea, Melisa F Mensegue, Carlos Jose Pirola
The Association between High Fat Diet around Gestation and Metabolic Syndrome-related Phenotypes in Rats: A Systematic Review and Meta-Analysis. Scientific reports 7 (1) (2017)
Silvia Sookoian, Carlos Jose Pirola
Letter: Mendelian randomisation to investigate moderate alcohol consumption in nonalcoholic fatty liver disease; modest effects need large numbers-authors' reply. Alimentary pharmacology & therapeutics 46 (4) (2017)
Silvia Sookoian, Carlos Jose Pirola
Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics 47 (1) (2017)
Silvia Sookoian, Gustavo O Castaño, Romina Scian, Tomas Fernández Gianotti, Hernán Dopazo, Cristian Rohr, Graciela Gaj, Julio San Martino, Ina Sevic, Diego Flichman, Carlos Jose Pirola
Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. The American journal of clinical nutrition 103 (2) (2016)

Carlos Jose Pirola.css-eqlu8i{font-size:small;padding-left:4px;} (Carlos J Pirola, C J Pirola)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos Jose Pirola (Carlos J Pirola, C J Pirola)